| Stage | CLS | % of rev | CSCO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.8B | 100.00% | $17.3B | 100.00% | CSCO ×2.96 |
| Gross profit | $641M | 10.99% | $11.1B | 64.13% | CSCO +53.1pp |
| Operating income | $460M | 7.89% | $4.3B | 24.72% | CSCO +16.8pp |
| Pre-tax income | $456M | 7.82% | $4.9B | 28.59% | CSCO +20.8pp |
| Net income | $397M | 6.81% | $3.9B | 22.37% | CSCO +15.6pp |
| Stage | CLS | CSCO | Gap · A − B |
|---|---|---|---|
| Revenue | $5.8B100.00% | $17.3B100.00% | CSCO ×2.96 |
| Gross profit | 10.99%$641M | 64.13%$11.1B | CSCO +53.1pp |
| Operating income | 7.89%$460M | 24.72%$4.3B | CSCO +16.8pp |
| Pre-tax income | 7.82%$456M | 28.59%$4.9B | CSCO +20.8pp |
| Net income |
| 6.81%$397M |
| 22.37%$3.9B |
| CSCO +15.6pp |
No shared counterparties.